Back to Journals » OncoTargets and Therapy » Volume 9

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

Total article views   HTML views PDF downloads Totals
8,320 Dovepress* 7,734+ 1,461 9,195
PubMed Central* 586 274 860
Totals 8,320 1,735 10,055
*Since 21 April 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar